Literature DB >> 18755578

Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.

D Vesprini1, Y Ung, R Dinniwell, S Breen, F Cheung, D Grabarz, J Kamra, K Mah, A Mansouri, G Pond, K Brock, G Darling, J Knox, M Haider, R K S Wong.   

Abstract

AIM: To evaluate the effect of the addition of fused positron emission tomography-computed tomography (PET-CT) imaging vs computed tomography alone in the identification of the gross tumour volume (GTV) in patients with gastro-oesophageal carcinoma.
MATERIALS AND METHODS: Ten patients with gastro-oesophageal cancer referred for radiation therapy underwent both (18F)fluoro-2-deoxy-d-glucose-PET (FDG-PET) and computed tomography in the treatment position. Image sets were anonymised and co-registered. Six radiation oncologists independently defined the GTV, first using the computed tomography data alone supplemented by standardised clinical and diagnostic imaging information, and second, using co-registered computed tomography and FDG-PET data (PET-CT). The standard deviation for both GTV length and volume (excluding involved lymph nodes) was taken as a measurement of inter-observer and intra-observer variability. Computer software that calculates volume overlap between contours was also used to generate an observer agreement index to compare intra- and inter-observer variability.
RESULTS: The addition of FDG-PET imaging decreased the median standard deviation for tumour length from 10 mm (range 8.1-33.3, mean 12.4 mm) for computed tomography alone to 8mm (range 4.4-18.1, mean 8.1 mm) for PET-CT (P = 0.02). Eight of the 10 patients showed an increase in volume of overlap between observers with the addition of FDG-PET imaging to the contouring process (P = 0.05). The average observer agreement index in PET-CT was 72.7% compared with 69.1% when using computed tomography alone. There was significantly less intra-observer variability in all measures when PET-CT was used. The median standard deviation in length improved from 5.3 to 1.8 mm, the median standard deviation in volume improved from 4.5 to 3 cm3 and the median observer agreement index improved from 76.2 to 78.7% when computed tomography alone was compared with PET-CT. The corresponding P values were 0.001, 0.033 and 0.022, respectively.
CONCLUSIONS: The addition of FDG-PET to computed tomography-based planning for the identification of primary tumour GTV in patients with gastro-oesophageal carcinoma decreases both inter-observer and intra-observer variability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755578     DOI: 10.1016/j.clon.2008.06.004

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  16 in total

1.  Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?

Authors:  Reubendra Jeganathan; James McGuigan; Frederick Campbell; Thomas Lynch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-16       Impact factor: 9.236

2.  Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.

Authors:  Katsuyuki Shirai; Akiko Nakagawa; Takanori Abe; Masahiro Kawahara; Jun-Ichi Saitoh; Tatsuya Ohno; Takashi Nakano
Journal:  Int J Mol Imaging       Date:  2012-05-14

3.  18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy

Authors:  Kinga Dębiec; Jerzy Wydmański; Izabela Gorczewska; Paulina Leszczyńska; Kamil Gorczewski; Wojciech Leszczyński; Andrea d’Amico; Michał Kalemba
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

4.  Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study.

Authors:  M E Nowee; F E M Voncken; A N T J Kotte; L Goense; P S N van Rossum; A L H M W van Lier; S W Heijmink; B M P Aleman; J Nijkamp; G J Meijer; I M Lips
Journal:  Clin Transl Radiat Oncol       Date:  2018-10-26

5.  Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation.

Authors:  Ryo Toya; Tomohiko Matsuyama; Tetsuo Saito; Masanori Imuta; Shinya Shiraishi; Yoshiyuki Fukugawa; Ayumi Iyama; Takahiro Watakabe; Fumi Sakamoto; Noriko Tsuda; Yoshinobu Shimohigashi; Yudai Kai; Ryuji Murakami; Yasuyuki Yamashita; Natsuo Oya
Journal:  J Radiat Res       Date:  2019-05-01       Impact factor: 2.724

6.  Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer.

Authors:  Tae Hoon Lee; Hyun Gee Ryoo; Reeree Lee; Jin Chul Paeng; Hyunsoo Chung; Hak Jae Kim
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

7.  The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.

Authors:  Yao-Ching Wang; Te-Chun Hsieh; Chun-Yen Yu; Kuo-Yang Yen; Shang-Wen Chen; Shih-Neng Yang; Chun-Ru Chien; Shih-Ming Hsu; Tinsu Pan; Chia-Hung Kao; Ji-An Liang
Journal:  J Radiat Res       Date:  2012-06-05       Impact factor: 2.724

Review 8.  The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies.

Authors:  J M Wilson; M Partridge; M Hawkins
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-07-04       Impact factor: 4.126

9.  The Impact of Positron Emission Tomography/Computed Tomography Addition to Contrast-Enhanced Computed Tomography Findings during Radiation Treatment Planning of Locally Advanced Carcinoma Esophagus.

Authors:  Sharad Bhatnagar; Shweta Sharma; Manoj Semwal; Sankalp Singh
Journal:  J Med Phys       Date:  2019-12-11

10.  Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT.

Authors:  Sophie E Vollenbrock; Marlies E Nowee; Francine E M Voncken; Alexis N T J Kotte; Lucas Goense; Peter S N van Rossum; Astrid L H M W van Lier; Stijn W Heijmink; Annemarieke Bartels-Rutten; Frank J Wessels; Berthe M P Aleman; Luc Dewit; Linda G W Kerkmeijer; Edwin P M Jansen; Martijn Intven; Irene M Lips; Gert J Meijer; Jasper Nijkamp
Journal:  Adv Radiat Oncol       Date:  2019-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.